Recent Advances in Diagnosis and Therapeutic Strategies in Intraocular Inflammation—Second Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 61
Special Issue Editor
Interests: ocular immune-mediated disorders; keratitis; immune pharmacology; uveitis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Intraocular inflammation remains a leading cause of visual impairment and a significant burden of legal and economic blindness. Although the molecular/immunological mechanisms of uveitis have been analyzed, leading to new findings, many details of the inflammatory processes remain unknown. Complex interactions, such as those involving “new” infectious agents, the host's genotype, and the modulation of the microbiome in non-infectious uveitis, are of increasing interest. The relevance of immune senescence and “inflammaging” extends to other interesting fields that remain uncovered. The complex immune–biologic scenario is often highly destructive and remains a challenge for early and accurate diagnosis and effective management. Therefore, the development of improved therapeutic modalities, both with intravitreal approaches and immune modulatory agents, has received intense attention from the uveitis research community.
This Special Issue aims to provide expert insight into current diagnostic and therapeutic procedures for infectious and non-infectious uveitis. Additionally, current developments in biomarkers for monitoring inflammation will be included. Both original papers and review articles will be considered for publication.
Prof. Dr. Uwe Pleyer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarker
- diagnosis
- immune pharmacology
- immune regulation
- immune system
- infection
- uveitis
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
